Flosequinan is a member of quinolines. Flosequinan was approved in the USA and the UK for a year prior to being withdrawn from the market due to increased mortality in chronic heart failure patients, found in drug trials. Its therapeutic use is listed as cardiovascular. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Manoplax and Flosequinanum. Its PubChem CID is 4474062.
Flosequinan
| CAS No | 76568-02-0 |
|---|---|
| Molecular Formula | C11H10FNO2S |
| Molecular Weight | 239.27 g/mol |
| Synonyms | 7-fluoro-1-methyl-3-methylsulfinylquinolin-4-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Flosequinan is a member of quinolines. Flosequinan was approved in the USA and the UK for a year prior to being withdrawn from the market due to increased mortality in chronic heart failure patients, found in drug trials.
The listed CAS number is 76568-02-0.
The listed molecular formula is C11H10FNO2S.
The listed molecular weight is 239.27 g/mol.
7-fluoro-1-methyl-3-methylsulfinylquinolin-4-one.
The source lists Manoplax and Flosequinanum.